Nav: Home

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer

February 15, 2017

DENVER - East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.

Lung cancer is the leading cause of cancer deaths worldwide, causing more deaths than breast, colon and prostate cancers combined. The risk factors for developing lung cancer include tobacco smoking, age, family history, medical or occupational radiation exposure and other chronic inflammatory diseases such as pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). Further, a history of prior cancer such as lymphoma, head and neck cancer or smoking-related cancer is considered to be a risk factor for developing second primary lung cancer (SPLC). Studies have also shown that second primary cancers, specifically esophageal cancer, can develop after receiving radiation therapy for a prior cancer. Interestingly, while radiation exposure is a known risk factor for lung cancer, it is not clear whether treatment with radiation therapy (RT) for breast cancer increases the risk of developing SPLC.

Taiwanese researchers conducted a study to evaluate whether breast cancer patients treated with RT are at greater risk for developing SPLC. The Taiwan Longitudinal Health Insurance Database (LHID), which is randomly abstracted from the National Health Insurance Research Database, was used to collect 986,713 patients with medical events from 2000 to 2010 for cohort analysis. All women with newly diagnosed invasive breast cancer, aged 18 years or older, and without other types of malignancy before 2000 or in the follow-up periods were enrolled in the study. Eligible patients were assigned to the radiation or non-radiation cohorts. Age, comorbidities, insurance premium, urbanization level, location, date of event and hospital care level were analyzed. Kaplan-Meier curve analysis and the log-rank test were used to demonstrate the cumulative risk for subsequent lung cancer. The hazard ratios of parameters were calculated by Cox regression analysis.

The results of the study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC), reported that of the 986,713 patients identified in the LHID, 7,408 female patients with breast cancer were eligible for the study. Among these, 5,696 patients underwent radiotherapy and 1,713 did not. At the end of the follow-up period, lung cancer had been diagnosed in 128 patients in the radiotherapy cohort (2.25%) and 4 patients in the non-radiation cohort (0.23%). Cox regression analysis showed that the adjusted hazard ratio was 10.08 times higher in the radiotherapy cohort than in the non-radiation cohort.

The authors comment that, "Treatment choices for breast cancer are multidisciplinary and include a combination of surgical resection, radiation, chemotherapy, hormone therapy and targeted therapy. This study investigated whether radiation, a frequently used therapeutic option for multidisciplinary treatment of breast cancer, subjected patients to a greater risk for SPLC in an East Asian country. The results of this study showed that radiation for breast cancer, which is an important treatment option, was correlated with a significant increase in the incidence of SPLC, particularly among older women or those with advanced-stage breast cancer. Regardless of the clinical or pathological stage, radiation for breast cancer also significantly increased the risk in the non-radiation cohort. Patients who undergo radiation for multidisciplinary treatment of breast cancer should be carefully monitored to detect potential SPLC."
-end-
About the IASLC

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 5,000 lung cancer specialists in over 100 countries. Visit http://www.iaslc.org for more information.

Written by: Jacinta Wiens, PhD, 720-598-1941; jacinta.wiens@iaslc.org

Media Contact: Becky Bunn, 720-254-9509; Becky.Bunn@iaslc.org

International Association for the Study of Lung Cancer

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
Blood test offers improved breast cancer detection tool to reduce use of breast biopsy
A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.